Great presentation by our Head of RA/QA, Dr. Ina Sarel at the Annual Conference for Regulation in Drug development and Production👏🏻 Ina shared valuable and cutting edge on regulatory challenges in scaling up production of Extracellular Vesicles.   Read More >>>

Happy to share recent scientific and business developments through EXITEAM CAPITAL PARTNERS!   Read More >>>

Our team members Dr. Lior Shaltiel, PhD, CEO, Dr. Ina Sarel, Head of CMC Quality and regulation, and Dr. Lyora Aharonov, Director of Research and Developments, will represent NurExone Biologic during the conference. Read More >>>

Meet our CEO Dr. Lior Shaltiel, PhD, CFO Eran Ovadya and Head of Communications and Investor Relations Inbar Paz Benayoun, Adv. to hear more of NurExone Biologic recent activity!

The Business workshop was truly a fantastic experience! The team at ModelZ brought a wealth of knowledge and expertise to the table, and their innovative approach to business strategy was both engaging and thought-provoking. The workshop was a great opportunity for our team to come together and collaborate on creating

This Wednesday (Feb 15th), I will attend the OurCrowd summit in Jerusalem. Happy to meet and discuss with individuals and potential Investors who are interested in NurExone Biologic‘s unique therapy and technology platform to treat damage in the Central Nervous System (#CNS) with the potential to treat Spinal Cord Injuries